Programme

Ireland Programme – Thursday 11th October 2018


17:00 – 18:00 Arrivals, badge collection & buffet dinner (from 17:30)
18:00 – 18:10 Welcome, Introduction and Overview of Agenda
Professor Elisabeth Vandenberghe
Consultant Haematologist, St. James’ Hospital, Dublin, Ireland
18:10 – 18:35 Targeting DNA damage response defects in haematological malignancies
Professor Tatjana Stankovic
Professor in Cancer Genetics, Institute of Cancer and Genomic Sciences, University of Birmingham, UK
18:35 – 19:00 The many facets of PI3K-delta in immune signalling and cancer
Professor Bart Vanhaesebroeck
Professor of Cell Signalling, UCL Cancer Institute, London
19:00 – 19:25 Advancing strategies to treat patients with relapse/refractory FL
Dr Derville O’Shea
Consultant Haematologist, Cork University Hospital, Ireland
19:25 – 19:30 Chair’s summary & close
Professor Elisabeth Vandenberghe
Consultant Haematologist, St. James’ Hospital, Dublin, Ireland

 

ONC/UK/18-02/NMAR/1080g(1)
Date of preparation: August 2018

This activity is intended for medical Haematology/Oncology specialists, Pathologists, Pharmacists, Nurses and other healthcare professionals involved in the management of CLL/FL. This is a medical education meeting organised and funded by Gilead Sciences Ltd., a science-based pharmaceutical company. This meeting is a medical education programme designed for healthcare professionals based in the UK and the Republic of Ireland only.